On behalf of the Executive Committee and the Board of Trustees, I extend warm wishes for a Happy New Year to our SIO members and supporters.
As we look forward to 2020, there are many exciting new things happening at SIO. The chairs of our committees, SIGs and Task Forces have already met to develop their strategic goals and themes for the coming year. The SIO2020 Conference Planning Committee has finalized the keynote and plenary speakers for our conference in Baltimore, MD, jointly sponsored by Johns Hopkins University. The call for abstracts and workshops will be announced soon.
2019 saw an increase in global membership, with 128 attendees representing 34 different countries at our International Conference in NYC (see the article below). Jun Mao, MD, has been working closely with Chasse Bailey-Dorton, MD, chair of the SIO Membership Task Force, and Santosh Rao, MD, SIO Treasurer and host of Integrative Oncology Talk podcast series, to identify ways to expand our reach and attract more members from around the world.
SIO's Executive Committee and Board of Trustees are working on obtaining a copyright for our name and logo, and work is advancing on improvements to our website to provide greater value to SIO members.
Thank you for your interest in and efforts on behalf of SIO. Our members are the driving force behind our growing society, and the work we do could not be accomplished without your efforts.
I look forward to working together as we expand awareness of integrative medicine and advance evidence-based research and treatment for cancer patients around the world.
SIO Call for Board Nominations
The Society for Integrative Oncology (SIO) is accepting nominations from SIO members to fill anticipated vacancies on its Board of Trustees. SIO welcomes the nomination of individuals who are researchers, clinicians, clinical researchers, patients and patient advocates. The submission deadline is March 31, 2020.
Eligibility: To be eligible, candidates must meet the following criteria:
• Current SIO Member (or will join)
• Interested in and committed to advancing and maintaining the integrity of integrative oncology
• Willing to contribute at least 5-10 hours per month toward SIO activities
• Willing to participate in SIO advancement, including fund raising
• Willing to participate in the annual SIO conference (2020 conference will be held October 16-18 in Baltimore, MD)
• Willing to participate in teleconference call meetings every other month and attend and participate in one annual Board retreat and meeting at the SIO Conference. (The 2020 daylong retreat to be held October 15 from 8 a.m.-4 p.m. in Baltimore, MD.)
• Willing to co-chair an SIO Committee, Task Force and/or Special Interest Group
Nomination Materials: Individuals may nominate themselves or others for consideration by sending the nomination along with the nominee’s curriculum vitae and/or resume, as well as a brief introductory paragraph or two stating the nominee’s qualifications, availability, and vision for serving on the SIO Board.
The identity of the nominator must be included with the nomination materials. If nominating someone other than yourself, acceptance of the nomination must be confirmed in writing via email from the nominee within one week of submission of the nomination.
The deadline for nomination submission is March 31, 2020.
Selection of Trustees: Nominations will be reviewed by the SIO Executive Committee and Board of Trustees, with a slate of nominees presented for vote to the SIO membership.
Trustee Terms: Each Trustee will serve a term of three years, with the possibility of a second term. Each trustee will be introduced to the SIO membership at the annual general meeting during the SIO Conference in October 2020 and will begin service at that time.
SIO2020 Keynote Speakers
The SIO2020 Conference Planning Committee has selected the keynote speakers for this year's conference in Baltimore. The speakers represent a diverse cross-section of disciplines within the field of integrative medicine, each with a special focus on key aspects of evidence-based research and treatment.
Jeffrey White, MD, board certified medical oncologist and cancer researcher, has served as Director of the NCI Office of Cancer Complementary and Alternative Medicine (OCCAM) since 1998. He has a deep interest in the biological sciences, particularly how science can be applied in real life to benefit health.
A distinguished cancer researcher, Dr. White has published numerous articles, abstracts, and book chapters in the field of oncology and he has lectured all over the world.
Dr. White has provided peer review for several journals, including the Journal of Clinical Oncology, and the Journal of the National Cancer Institute. Currently, he is associate editor for Cancer Investigation and the Encyclopedia of Dietary Supplements, and editor-in-chief for the Complementary and Alternative Medicine Editorial Board at NCI.
At his keynote presentation, Dr. White will discuss OCCAM’s current and future priorities and plans for investment in research on the science of living well with cancer.
Mary Armanios, MD, is Associate Professor in the Department of Oncology and the McKusick-Nathans Institute of Genetic Medicine at the Johns Hopkins University School of Medicine. Her clinical and research interests focus on understanding the role of telomeres in disease.
Dr. Armanios oversees the clinical operations of the Johns Hopkins-based Telomere Center, which aims to advance the diagnosis and management of telomere disorders in both children and adults.
Her presentation will address the intersection of aging and cancer and illuminate the interplay of telomere length and tumor growth to provide the biological context for understanding the role of integrative therapies, which have been shown to influence telomere length and improve quality of life.
A global leader in cancer research and health disparities, Otis Brawley, MD, of Johns Hopkins University, is a leading voice in the thoughtful development of cancer screening strategies and ensuring their effectiveness. A dedicated teacher, he trains the next generation of physicians and researchers to reduce the threat of cancer.
As the Bloomberg Distinguished Professor, Bloomberg School of Public Health, he continues his work exploring how health care, especially oncology, is practiced. He sees this as an opportunity to be vocal about the appropriate interpretation and application of science to relieve human suffering.
Dr. Brawley will highlight elements of the growing body of evidence showing that sociological and demographic disparities, rather than race-related biological differences, largely explain cancer inequalities, directly leading to impaired quality of life in minority groups.
Bonnie Kaplan, PhD, Professor Emeritus in the Cumming School of Medicine at the University of Calgary, is the recipient of the 2019 Dr. Rogers Prize for Excellence in Complementary and Alternative Medicine, and a pioneer in the complementary and alternative medicine (CAM) field known as nutritional psychiatry or nutritional psychology.
Since 2001, Dr. Kaplan has been roving that treating mental health challenges (explosive rage, mood symptoms, and anxiety) with balanced, broad-spectrum nutrient treatment formulas is more effective than using a single nutrient as treatment. She also provided the initial ground-breaking data showing that treatment with carefully constructed formulations of broad-spectrum micronutrients could be used instead of psychotropic drugs to treat bipolar disorder and attention deficit hyperactivity disorder (ADHD).
In 2009, she led a team of 12 scientists to determine the relationships between maternal nutrient intake before, during, and after gestation on maternal mood, birth outcome, and infant neurodevelopment.
She has written over 140 peer-reviewed scientific articles, 120 commentaries and reviews, and 11 book chapters on the subject of nutrition and brain health, and she has been a research supervisor or committee member for 78 graduate and undergraduate students.
Dr. Kaplan will discuss the role of nutrition and micronutrients on mental health and resilience in cancer and other populations.
SIO's Global Map Continues to Grow
2019 was a very good year for SIO's global expansion. The 16th International Conference welcomed physicians, patient advocates, and allied health professionals from 34 countries who presented on a diverse range of topics and attended the conference's international networking breakfast on Day Two. Jun Mao, MD, Memorial Sloan Kettering Cancer Center, and Santosh Rao, MD, of MD Anderson, were instrumental in organizing the breakfast and facilitating a fruitful and productive dialogue focused on the state of integrative oncology in different parts of the world.
SIO Website is Getting a Re-Design!
SIO's Communications Committee has formed a Website Update Task Force, led by incoming Communications Comittee co-chair, Sheila Garland, MD, and including Patient Advocacy Task Force (PATF) Chair, Betsy Glosik, and PATF members Jodi MacLeod and Teresa Martin.
In 2019, SIO committees, SIGs and task forces identified key areas where the website could be improved for overall appearance, accessibility and impact.
Updates will be made available as work advances on this important initiative.
Important Deadline Updates
The Official Journal of:
JACM Paradigm, Practice, and Policy Advancing Integrative Health The Journal of Alternative and Complementary Medicine
INVITATION TO SUBMIT
Special Focus Issue on Integrative Palliative Care
The fields of Palliative Care and Integrative Health have both advanced substantially over the past two decades. These movements share many fundamental values—patient-centeredness, respecting the body-mind-spirit whole person continuum, and supportive and complementary roles; yet the fields have grown in parallel rather than intentionally examining their shared mission. In 2020, JACM: Paradigm, Practice and Policy Advancing Integrative Health (The Journal of Alternative and Complementary Medicine) will publish a Special Focus Issue on Integrative Palliative Care. The goal will be to enhance the natural synergy between integrative health and palliative medicine by drawing research and commentary that examine integrative palliative care. (For more reflection on the convergence, please see Adler et al “ Integrative Palliative Care: Enhancing the Natural Synergy Between Integrative Health and Palliative Medicine” JACM, March 2019).
Click here for more details and to submit your manuscript.
Trans NCI-NIH Conference on International Perspectives on Integrative Medicine
May 20-21, 2020
The Center for Global Health and the Office of Cancer Complementary and Alternative Medicine (OCCAM) of the National Cancer Institute of the U.S. National Institutes of Health (NCI-NIH), will host the Trans-NCI-NIH Conference on International Perspective on Integrative Medicine for Cancer Prevention and Cancer Patient Management.
The main aims of the conference are to discuss the integration of traditional, complementary and alternative medicine (TCAM) with conventional cancer prevention and treatment approaches in global health, thus forming new approaches to integrative oncology; and discuss approaches for strengthening integrative oncology research in low-and-middle-income-countries (LMICs).
Read More Here and Register.
Hurry! Seating is Limited to 400
Be sure to tune in to Episode 8 of the SIO-sponsored podcast, Integrative Oncology Talk. This latest episode, "The Intersection of Conventional and Complementary Therapies," features Debu Tripathy, MD, professor of medicine and chair, department of breast medical oncology at The University of Texas MD Anderson Cancer Center. His clinical research focuses on the evaluation and development of new therapies in breast cancer, specifically growth factor receptor pathway targeting and biomarkers that predict sensitivity and resistance.
Dr. Tripathy is a past president of the Society for Integrative Oncology. In this podcast, he and Dr. Rao discuss complexities in integrative oncology research, how research can advance the use of integrative oncology and its perception, how to find mentorship, and the importance of translating research into clinical practice.
Integrative Oncology Talk episodes are available through Apple Podcasts and wherever you access podcasts.
Herb of the Month - Lavender
We chose lavender for this issue because it is increasingly employed to relieve anxiety, depression, intestinal problems, and pain. Cultivated in many parts of the world as an ornamental plant, lavender is also commonly used by itself or in combination with other essential oils for massage and in aromatherapy.
Data from clinical studies indicate utility of lavender aromatherapy for improving memory loss in patients with dementia. It also lowers preoperative anxiety and reduces the need for pain medication following surgery. In addition, findings suggest improvements in sleep quality, dysmenorrhea and emotional symptoms, renal colic, along with reductions in the severity of migraine headaches.
Oral preparations of lavender have been reported to mitigate symptoms in patients with mild to moderate depression, and in those with generalized anxiety disorder.
Preclinical findings indicate anticancer effects, but lavender did not have any benefits in cancer patients undergoing radiotherapy, nor did it augment the effects of massage.
This resource is provided with thanks to the Integrative Medicine Service at Memorial Sloan Kettering Cancer Center, which maintains a free web site, About Herbs, Botanicals and Other Products.
Show Your Support of SIO
SIO welcomes your support of our Society, which helps us undertake projects and educational programs, allowing us to realize our mission of advancing evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer.
In 2019, SIO raised $4,600.00, which will allow us to support one person from Africa to attend SIO2020 in Baltimore.